Haemonetics Raises Fiscal 2027 Organic Revenue Growth Outlook to 6% to 9%

Second-quarter organic revenue rose 10% in the period ended Sept. 26, 2026. CSL expects its U.S. center rollout to finish by the end of 2027.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.